3rd Circ. Won't Revive Off-Label Suit Over Teva Heart Drug
The Third Circuit has declined to revive two cases against Teva Pharmaceuticals USA Inc. alleging the company failed to warn patients about side effects associated with the off-label use of heart...To view the full article, register now.
Already a subscriber? Click here to view full article